DRUG ABUSE OFFICE AND TREATMENT ACT OF 1972 CONFERENCE REPORT

• Document Type: CREST
• Collection: General CIA Records
• Document Number (FOIA) /ESDN (CREST): CIA-RDP73B00296R000400080001-9
• Release Decision: RIFPUB
• Original Classification: K
• Document Page Count: 34
• Document Creation Date: December 9, 2016
• Document Release Date: August 21, 2000
• Sequence Number: 1
• Publication Date: March 17, 1972
• Content Type: REPORT

Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
92D CONGRESS 1 SENATE REPORT
2d Session I No. 92-700
DRUG ABUSE OFFICE AND TREATMENT ACT OF 1972
Mr. HUGHES, from the committee of conference,
submitted the following
CONFERENCE REPORT
The committee of conference on the disagreeing votes of the two
Houses on the amendment of the House to the bill (S. 2097) to estab-
lish a Special Action Office for Drug Abuse Prevention and to con-
centrate the resources of the Nation against the problem of drug
abuse, having met, after full and free conference, have agreed to
recommend and do recommend to their respective Houses as follows:
That the Senate recede from its disagreement to the amendment of
the House and agree to the same with an amendment as follows:
In lieu of the matter proposed to be inserted by the House amend-
ment insert the following:
? 1. Short title.
This Act may be cited as the "Drug Abuse Office and Treatment Act of
1972".
TITLE I-FINDINGS AND DECLARATION OF POLICY;
DEFINITIONS; TERMINATION
Sec.
101. Congressional findings.
102. Declaration of national policy.
103. Definitions.
104. Termination.
? 101. Congressional findings.
The Congress makes the following findings:
(1) Drug abuse is rapidly increasing in the United States and now
afflicts urban, suburban, and rural areas of the Nation.
(2) Drug abuse seriously impairs individual, as well as societal,
health and well-being.
Approved For Rglftage 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
2
(3) Drug abuse, especially heroin addiction, substantially con-
tributes to crime.
(4) The adverse impact of drug abuse inflicts increasing pain and
hardship on individuals, families, and communities and undermines
our institutions.
(5) Too little is known about drug abuse, especially the causes,
and ways to treat and prevent drug abuse.
(6) The success of Federal drug abuse programs and activities
requires a recognition that education, treatment, rehabilitation, re-
search, training, and law enforcement efforts are interrelated.
(7) The effectiveness of efforts by State and local governments and
by the Federal Government to control and treat drug abuse in the
United States has been hampered by a lack of coordination among
the States, between States and localities, among the Federal Govern-
ment, States, and localities, and throughout the Federal establishment.
(8) Control of drug abuse requires the development of a compre-
hensive, coordinated long-term Federal strategy that encompasses both
effective law enforcement against illegal drug traffic and effective
health programs to rehabilitate victims of drug abuse.
(9) The increasing rate of drug abuse constitutes a serious and
continuing threat to national health and welfare, requiring an imme-
diate and effective response on the part of the Federal Government.
? 102. Declaration of national policy.
The Congress declares that it is the policy of the United States and the
purpose of this Act to focus the comprehensive resources of the Federal
Government and bring them to bear on drug abuse with the immediate
objective of significantly reducing the incidence of drug abuse in the
United States within the shortest possible period of time, and to develop a
comprehensive, coordinated long-term Federal strategy to combat drug
abuse.
? 103. Definitions.
(a) The definitions set forth in this section apply for the purposes of
this Act.
(b) The term "drug abuse prevention function" means any program or
activity relating to drug abuse education, training, treatment, rehabili-
tation, or research, and includes any such function even when performed
by an organization whose primary mission is in the field of drug traffic
prevention functions, or is unrelated to drugs. The term does not include
any function defined in subsection (c) as a "drug traffic prevention
function".
(c) The term "drug traffic prevention function" means
(1) the conduct of formal or informal diplomatic or international
negotiations at any level, whether with foreign governments, other
foreign governmental or nongovernmental persons or organizations
of any kind, or any international organization of any kind, relating
to traffic (whether licit or illicit) in drugs subject to abuse, or any
measures to control or curb such traffic; or
(2) any of the following law enforcement activities or proceedings:
(A) the investigation and prosecution of drug offenses;
(B) the impanelment of grand juries;
(C) programs or activities involving international narcotics
control; and
(D) the detection and suppression of illicit drug supplies.
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
3
? 104. Termination.
Effective June 30, 1975, the Office, each of the positions in the Office
of Director, Deputy Director, and Assistant Director, and the National
Advisory Council for Drug Abuse Prevention established by section 251
of this Act are abolished and title II is repealed.
TITLE II-SPECIAL ACTION OFFICE FOR DRUG ABUSE
PREVENTION
Chapter Section
1. GENERAL PROVISIONS------------- -------------------------------------------- 201
2. FUNCTIONS OF THE DIRECTOR -------------------------------------- 221
3. ADVISORY COUNCIL-------------------- - ------------------------ 261
Chapter 1.-GENERAL PROVISIONS
Sec.
201. Establishment of Office.
202. Appointment of Director.
208. Appointment of Deputy Director.
204. Appointment of Assistant Directors.
205. Delegation.
206. Officers and employees.
207. Employment of experts and consultants.
208. Acceptance of uncompensated services.
209. Notice relating to the control of dangerous drugs.
210. Grants and contracts.
211. Acting Director and Deputy Director.
212. Compensation of Director, Deputy Director, and Assistant Directors.
213. Statutory requirements unaffected.
214. Appropriations authorized.
? 201. Establishment of Office.
There is established in the Executive Office of the President an office
to be known as the Special Action Office for Drug Abuse Prevention
(hereinafter in this Act referred to as the "Office"). The establishment of
the Office in the Executive Office of the President shall not be construed
as affecting access by the Congress, or committees of either House, (1) to
information, documents, and studies in the possession of, or conducted by,
the Office, or (2) to personnel of the Office.
? 202. Appointment of Director.
There shall be at the head of the Office a Director who shall be appointed
by the President, by and with the advice and consent of the Senate.
? 203. Appointment of Deputy Director.
There shall be in. the Office a Deputy Director who shall be appointed
by the President, by and with the advice and consent of the Senate. The
Deputy Director shall perform such functions as the Director may assign
or delegate, and shall act as Director during the absence or disability of the
Director or in the event of a vacancy in the office of Director.
? 204. Appointment of Assistant Directors.
There shall be in the Office not to exceed six Assistant Directors appointed
by the Director.
? 205. Delegation.
Unless specifically prohibited by law, the Director may, without being
relieved of his responsibility, perform any of his functions or duties, or
exercise any of his powers through, or with the aid of, such persons in, or
organizations of, the Office as he may designate.
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
4
? 206. Officers and employees.
(a) The Director may employ and prescribe the functions of such
o cers and employees, including attorneys, as are necessary to perform
t e functions vested in him. At the discretion of the Director, any officer
or employee of the Office may be allowed and paid travel expenses, in-
cluding per diem in lieu of subsistence, in the same manner as is au-
thorized by section 5703 of title 5, United States Code, for individuals
employed intermittently.
(b) In addition to the number of positions which may be placed in
grades GS-16, 17, and 18 under section 5108 of title 5, United States
Code, and without prejudice to the placement of other positions in the
Office in such grades under any authority other than this subsection, not
to exceed ten positions, in the O,~ce may be placed in grades GS-16, 17,
and 18, but in accordance with the procedures prescribed under such
section 5108. The authority for such additional positions shall terminate
on the date specified in section 104 of this Act.
? 207. Employment of experts and consultants.
The Director may procure services as authorized by section 3109 of
title 5, United States Code, and may pay a rate for such services not in
excess of the rate in effect for grade GS-18 of the General Schedule. The
Director may employ individuals under this section without regard to
any limitation, applicable to services procured under such section 3109,
on the number of days or the period of such services, except that, at any
one time, not more than fifteen individuals may be employed under this
section without regard to such limitation.
? 208. Acceptance of uncompensated services.
The Director is authorized to accept and employ in furtherance of the
purpose of this Act or any Federal drug abuse prevention function,
voluntary and uncompensated services notwithstanding the provisions of
section 3679(b) of the Revised Statutes (31 U.S.C. 665(b)).
? 209. Notice relating to the control of dangerous drugs.
Whenever the Attorney General determines that there is evidence that
(1) a drug or other substance, which is not a controlled substance
(as defined in section 101 (6) of the Controlled Substances Act), has
a potential for abuse, or
(2) a controlled substance should be transferred or removed from
a schedule under section 202 of such Act,
he shall, prior to initiating any proceeding under section 201 (a) of such
Act, give the Director timely notice of such determination. Information
forwarded to the Attorney General pursuant to section 201(f) of such Act
shall also be forwarded by the Secretary of Health, Education, and
Welfare to the Director.
? 210. Grants and contracts.
(a) In carrying out any of his functions under this title, the Director
is authorized to make grants to any public or nonprofit private agency,
organization, or institution, and to enter into contracts with any agency,
organization, or institution, or with any individual.
(b) To the extent he deems it appropriate, the Director may require
the recipient of a grant or contract under this section to contribute
money, facilities, or services for carrying out the program and activity
for which such grant or contract was made.
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-FDP73B00296R000400080001-9
(c) Payments pursuant to a grant or contract under this section may
be made (after necessary adjustment, in the case of grants, on account of
previously made overpayments or underpayments) in advance or by way of
reimbursements, and in such installments and on such conditions as the
Director may determine.
(d) Any Federal department or agency may enter into grant or contrac-
tual arrangements with the Director and, pursuant to such a grant or
contractual arrangement, may exercise any authority to use any personnel
or facilities which would otherwise be available to such department or
agency for the performance by it of its authorized functions.
? 211. Acting Director and Deputy Director.
The President may authorize any person who immediately prior to the
date of enactment of this Act held a position in the executive branch of the
Government to act as the Director or Deputy Director until the position in
question is for the first time filled pursuant to the provisions of this title or
by recess appointment, as the case may be, and the President may authorize
any such person to receive the compensation attached to the office in respect
of which he serves. Such compensation, if authorized, shall be in lieu of
but not in addition to other compensation from the United States to which
such person may be entitled.
? 212. Compensation of Director, Deputy Director, and Assistant
Directors.
(a) Section 5313 of title 5, United States Code, is amended by adding
at the end thereof the following:
"(21) Director of the Special Action Office for Drug Abuse
Prevention."
(b) Section 5315 of title 5, United States Code, is amended by adding
at the end thereof the following:
"(95) Deputy Director of the Special Action Office for Drug Abuse
Prevention."
(c) Section 5316 of title 5, United States Code, is amended by adding
at the end thereof the following:
"(131) Assistant Directors, Special Action Office for Drug Abuse
Prevention (6)."
? 213. Statutory requirements unaffected.
Except as authorized in section 225, nothing in this Act authorizes
or permits the Director or any other Federal officer to waive or disregard
any limitation or requirement, including standards, criteria, or cost-
sharing formulas, prescribed by law with respect to any Federal program
or activity. Except with respect to the conduct of drug abuse prevention
functions, nothing in this Act shall be construed to limit the authority
of the Secretary of Defense with respect to the operation of the armed
forces or the authority of the Administrator of Veterans' Affairs with
respect to furnishing health care to veterans.
? 214. Appropriations authorized.
(a) (1) For the purposes of carrying out the provisions of this title, ex-
cept for the provisions of sections 228 and 224, there are authorized to
be appropriated $5,000,000 for the fiscal year ending June 30, 1972;
$10,000,000 for the fiscal year ending June 30, 1973; $11,000,000 for
the fiscal year ending June 30, 1974; and $12,000,000 for the fiscal
year ending June 30, 1975.
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
6
(2) For the purpose of carrying out the provisions of section 223, there
is authorized to be appropriated $40,000,000 for each of the fiscal years
ending June 30, 1973, June 30, 1974, and June 30, 1975.
(3) For the purpose of making grants and contracts under section 224,
there are authorized to be appropriated $20,000,000 for the fiscal year
ending June 30, 1973, $25,000,000 for the fiscal year ending June 30,
1974, and $30,000,000 for the fiscal year ending June 30, 1975.
(b) Sums appropriated under subsection (a) of this section shall
remain available for obligation or expenditure in the fiscal year for which
appropriated and in the fiscal year next following.
Chapter 2.-FUNCTIONS OF THE DIRECTOR
Sec.
221. Concentration of Federal effort.
222. Funding authority.
223. Special Fund.
224. Encouragement of certain research and development.
225. Single non-Federal share requirement.
226. Recommendations regarding drug traffic prevention functions.
227. Resolution of certain conflicts.
228. Liaison with respect to drug traffic prevention.
229. Technical assistance to State and local agencies.
230. Management oversight review.
231. Federal drug council authorized.
232. International negotiations.
233. Annual report.
? 221. Concentration of Federal effort.
(a) The Director shall provide overall planning and policy and establish
objectives and priorities for all Federal drug abuse prevention functions.
In carrying out his functions under this subsection, the Director shall
consult, from time to time, with the National Advisory Council for Drug
Abuse Prevention.
(b) For the purpose of assuring the effectuation of the planning and
policy and the achievement of the objectives and priorities provided or
established pursuant to subsection (a), the Director shall
(1) review the regulations, guidelines, requirements, criteria, and
procedures of operating agencies in terms of their consistency with
the policies, priorities, and objectives he provides or establishes, and
assist such agencies in making such additions thereto or changes
therein as may be appropriate;
(2) recommend changes in organization, management, and
personnel, which he deems advisable to implement the policies,
priorities, and objectives he provides or establishes;
(3) review related Federal legislation in the areas of health,
education, and welfare providing for medical treatment or assistance,
vocational training, or other rehabilitative services and, consistent
with the purposes of this Act, assure that the respective administering
agencies construe drug abuse as a health problem;
(4) conduct or provide for the conduct of evaluations and studies
of the performance and results achieved by Federal drug abuse
prevention functions, and of the prospective performance and results
that might be achieved by alternative programs and activities sup-
plementary to or in lieu of those currently being administered;
(5) require departments and agencies engaged in Federal drug
abuse prevention functions to submit such information and reports
with respect thereto as the Director determines to be necessary to
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73Bb0296R000400080001-9
7
carry out the purposes of this Act, and such departments and agencies
shall submit to the Director such information and reports as the
Director may reasonably require;
(6) except as provided in the second sentence of section 213,
(A) coordinate the performance of drug abuse prevention
functions by Federal departments and agencies; and
(B) coordinate the performance of such functions by Federal
departments and agencies with the performance by Federal
departments and agencies of other functions which the Director
determines may have an important bearing on the success of
the entire Federal e, fort against drug abuse; and
(7) develop improved methods for determining the extent of drug
addiction and abuse in the United States.
? 222. Funding authority.
In implementation of his authority under section 221, and to carry
out the purposes of this Act, the Director is authorized
(1) to review and as he deems necessary modify insofar as they
pertain to Federal drug abuse prevention functions,
(A) implementation plans for any Federal program, and
(B) the budget requests of any Federal department or agency;
and
(2) to the extent not inconsistent with the applicable appropriation
Acts, to make funds available from appropriations to Federal depart-
ments and agencies to conduct drug abuse prevention functions.
? 223. Special Fund.
(a) There is established a Special Fund (hereinafter in this section
referred to as the "fund") in order to provide additional incentives to
Federal departments and agencies to develop more effective drug abuse
prevention functions and to give the Director the flexibility to encourage,
and respond quickly and effectively to, the development of promising pro-
grams and approaches.
(b) Except as provided in subsection (c) of this section, sums appro-
priated to the fund may be utilized only after their transfer, upon the order
of the Director and at his discretion, to any Federal department or agency
(other than the Office) and only for the purpose of
(1) developing or demonstrating promising new concepts or meth-
ods in respect of drug abuse prevention functions; or
(2) supplementing or expanding existing drug abuse prevention
functions which the Director finds to be exceptionally effective or for
which he finds there exists exceptional need.
(c) Not more than 10 per centum of such sums as are appropriated
to the fund may be expended by the Director through the Office to develop
and demonstrate promising new concepts or methods in respect of drug
abuse prevention functions.
?224. Encouragement of certain research and development.
In carrying out his functions under section 221, the Director shall
encourage and promote (by grants, contracts, or otherwise) expanded
research programs to create, develop, and test
(1) nonaddictive synthetic analgesics to replace opium and its
derivatives in medical use;
(2) long-lasting, nonaddictive blocking or antagonistic drugs or
other pharmacological substances for treatment of heroin addiction;
and
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
8
(3) detoxification agents which, when administered, will ease the
physical effects of withdrawal from heroin addiction.
In carrying out this section the Director is authorized to establish, or
provide for the establishment of, clinical research facilities.
? 225. Single non-Federal share requirement.
Where funds are made available by more than one Federal agency to be
used by an agency, organization, or individual to carry out a drug abuse
prevention function, a single non-Federal share requirement may be estab-
lished according to the proportion of funds advanced by each Federal
agency, and the Director may order any such agency to waive any technical
grant or contract requirement established in regulations which is incon-
sistent with the similar requirement of the other Federal agency or which
the other Federal agency does not impose.
? 226. Recommendations regarding drug traffic prevention func-
tions.
The Director may make recommendations to the President in connection
with any Federal drug traffic prevention function, and shall consult with
and be consulted by all responsible Federal departments and agencies
regarding the policies, priorities, and objectives of such functions.
? 227. Resolution of certain conflicts.
If the Director determines in writing that the manner in which any
Federal department or agency is conducting any drug abuse prevention
function or drug traffic prevention function substantially impairs the
effective conduct of any other such function, he shall submit in writing his
findings and determinations to the President, who may direct the Federal
department or agency in question to conduct the function thereafter under
such policy guidelines as the President may specify to eliminate the
impairment.
? 228. Liaison with respect to drug traffic prevention.
One of the Assistant Directors of the Office shall maintain communica-
tion and liaison with respect to all drug traffic prevention functions of
the Federal Government.
? 229. Technical assistance to State and local agencies.
(a) The Director shall
(1) coordinate or assure coordination of Federal drug abuse
prevention functions with such functions of State and local govern-
ments; and
(2) provide for a central clearinghouse for Federal, State, and
local governments, public and private agencies, and individuals
seeking drug abuse information and assistance from the Federal
Government.
(b) In carrying out his functions under this section, the Director may
(1) provide technical assistance-including advice and consulta-
tion relating to local programs, technical and professional assistance,
and, where deemed necessary, use of task forces of public officials or
other persons assigned to work with State and local governments-
to analyze and identify State and local drug abuse problems and
assist in the development of plans and programs to meet the problems
so identified;
(2) convene conferences of State, local, and Federal officials, and
such other persons as the Director shall designate, to promote the
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
9
purposes of this Act, and the Director is authorized to pay reasonable
expenses of individuals incurred in connection with their participa-
tion in such conferences;
(3) draft and make available to State and local governments model
legislation with respect to State and local drug abuse programs and
activities; and
(4) promote the promulgation of uniform criteria, procedures, and
forms of grant or contract applications for drug abuse control and
treatment proposals submitted by State and local governments and
private organizations, institutions, and individuals.
(c) In implementation of his authority under subsection (b) (1), the
Director may
(1) take such action as may be necessary to request the assignment,
with or without reimbursement, of any individual employed by any
Federal department or agency and engaged in any Federal drug abuse
prevention function or drug traffic prevention function to serve as a
member of any such task force; except that no such person shall be so
assigned during any one fiscal year for more than an aggregate of
ninety days without the express approval of the head of the Federal
department or agency with respect to which he was so employed prior
to such assignment;
(2) assign any person employed by the Office to serve as a member
of any such task force or to coordinate management of such task
forces; and
(3) enter into contracts or other agreements with any person or
organization to serve on or work with such task forces.
? 230. Management oversight review.
The Director may, for a period not to exceed thirty days in any one
calendar year, provide for the exercise or performance of a management
oversight review with respect to the conduct of any Federal drug abuse
prevention function. Such review may be conducted by an officer of any
Federal department or agency other than the department or agency con-
ducting such function. The officer shall submit a written report to the
Director concerning his findings.
? 231. Federal drug council authorized.
To promote the purposes of this Act, the Director may convene, at his
discretion, a council of officials representative of Federal departments
and agencies, including intelligence agencies, responsible for Federal
drug abuse prevention functions or Federal drug traffic prevention
functions.
? 232. International negotiations.
The President may designate the Director to represent the Government
of the United States in discussions and negotiations relating to drug abuse
prevention, drug traffic prevention, or both.
? 233. Annual report.
The Director shall submit to the President and the Congress, prior to
March 1 of each year which begins after the enactment of this title, a
written report on the activities of the Office. The report shall specify the
objectives, activities, and accomplishments of the Office, and shall contain
an accounting of funds expended pursuant to this title.
S. Rept. 700 0, 92-2-2
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
10
Chapter 3.-ADVISORY COUNCIL
Sec.
251. Establishment of Council.
252. Membership of the Council.
253. Chairman; meetings.
254. Compensation and expenses.
255. Functions of the Council.
251. Establishment of Council.
There is established a National Advisory Council for Drug Abuse Pre-
vention (hereinafter in this chapter referred to as the "Council") which
shall consist of fifteen members.
? 252. Membership of the Council.
(a) The Secretary of Health, Education, and Welfare, the Secretary
of Defense, and the Administrator of Veterans' Affairs, or their respective
designees, shall be members of the Council ex officio.
(b) The remaining members of the Council shall be appointed by the
President and shall serve at his pleasure. Appointments shall be made
from persons who by virtue of their education, training, or experience
are qualified to carry out the functions of members of the Council. Of the
members so appointed, four shall be officials of State or local governments
or governmental agencies who are actively engaged in drug abuse preven-
tion functions.
? 253. Chairman; meetings.
The President shall designate the Chairman of the Council. The
Council shall meet at the call of the Chairman, but not less often than
four times a year.
? 254. Compensation and expenses.
Members of the. Council (other than members who are full-time officers
or employees of the United States) shall, while serving on business of
the Council, be entitled to receive a per diem allowance at rates not to
exceed the daily equivalent of the rate authorized for grade GS-18 of the
General Schedule. Each member of the Council, while so serving away
from his home or regular place of business, may be allowed actual travel
expenses and per diem in lieu of subsistence as authorized by section
5703 of title 5 of the United States Code for persons in the Government
service employed intermittently.
? 255. Functions of the Council.
(a) The Council shall, from time to time, make recommendations to
the Director with respect to overall planning and policy and the objectives
and priorities for all Federal drug abuse prevention functions.
(b) The Council may make recommendations to the Director with
respect to the conduct of, or need for, any drug abuse prevention functions
which are or in its judgment should be conducted by or with the support
of the Federal Government.
TITLE III-NATIONAL DRUG ABUSE STRATEGY
sec.
301. Development of strategy required.
302. Strategy Council.
303. Content of strategy.
304. Preparation of strategy.
305. Review and revision.
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
11
? 301. Development of strategy required.
Immediately upon the enactment of this title, the President shall direct
the development of a comprehensive, coordinated long-term Federal
strategy (hereinafter in this title referred to as the "strategy") for all
drug abuse prevention functions and all drug traffic prevention functions
conducted, sponsored, or supported by any department or agency of
the Federal Government. The strategy shall be initially promulgated
by the President no later than nine months after the enactment of this title.
302. Strategy Council.
To develop the strategy, the President shall establish a Strategy Council
whose membership shall include the Director of the Special Action Office
for Drug Abuse Prevention until the date specified in section 104 of this
Act, the Attorney General, the Secretaries of Health, Education, and
Welfare, State, and Defense, the Administrator of Veterans' Affairs,
and other officials as the President may deem appropriate. Until the date
specified in section 104 of this Act, the Director shall provide such services
as are required to assure that the strategy is prepared, and thereafter such
services shall be provided by such officer or agency of the United States as
the President may designate. The strategy shall be subject to review and
written comment by those Federal officials participating in its preparation.
? 303. Content of strategy.
The strategy shall contain
(1) an analysis of the nature, character, and extent of the drug
abuse problem in the United States, including examination of the
interrelationships between various approaches to solving the drug
abuse problem and their potential for interacting both positively and
negatively with one another;
(2) a comprehensive Federal plan, with respect to both drug abuse
prevention functions and drug traffic prevention functions, which
shall specify the objectives of the Federal strategy and how all avail-
able resources, funds, programs, services, and facilities authorized
under relevant Federal law should be used; and
(3) an analysis and evaluation of the major programs conducted,
expenditures made, results achieved, plans developed, and problems
encountered in the operation and coordination of the various Federal
drug abuse prevention functions and drug traffic prevention functions.
? 304. Preparation of strategy.
To facilitate the preparation of the strategy, the Council shall
(1) engage in the planning necessary to achieve the objectives of a
comprehensive, coordinated long-term Federal strategy, including
examination of the overall Federal investment to combat drug abuse;
(.2) at the request of any member, require departments and agencies
engaged in Federal drug abuse prevention functions and drug traffic
prevention functions to submit such information and reports and to
conduct such studies and surveys as are necessary to carry out the
purposes of this title, and the departments and agencies shall submit
to the Council and to the requesting member the information, reports,
studies, and surveys so required;
(3) evaluate the performance and results achieved by Federal
drug abuse prevention functions and drug traffic prevention func-
tions and the prospective performance and results that might be
achieved by programs and activities in addition to or in lieu of those
currently being administered.
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
12
? 305. Review and revision.
The strategy shall be reviewed, revised as necessary, and promulgated
as revised from time to time as the President deems appropriate, but not
less often than once a year.
'Sec.
401. Community mental health centers.
402. Public Health Service facilities.
403. State plan requirements.
404. Drug abuse prevention function appropriations.
405. Special reports by the Secretary of Health, Education, and Welfare.
406. Additional drug abuse prevention functions of the Secretary of Health, Educa-
tion, and Welfare.
407. Admission of drug abusers to hospitals for emergency treatment.
408. Confidentiality of patient records.
409. Formula grants.
410. Special project grants and contracts.
411. Records and audit.
412. National Drug Abuse Training Center.
413. Drug abuse among Federal civilian employees.
? 401. Community mental health centers.
(a) Section 221 of the Community Mental Health Centers Act (42
U.S.C. 2688a) is amended by adding at the end thereof the following new
subsection:
"(c) If an application for a grant under this part for a community
mental health center is made for any fiscal year beginning after June 30,
1972, and-
"(1) the Secretary determines that it is feasible for such center to
provide a treatment and rehabilitation program for drug addicts and
other persons with drug abuse and other drug dependence problems
residing in the area served by the center and that the need for such a
program in that area is of such a magnitude as to warrant the pro-
vision of such a program by the center, such application may not be
approved unless it contains or is supported by assurances satisfactory
to the Secretary that the center will provide such program in such
fiscal year; or
"(2) the Secretary determines that it is feasible for the center to
assist the Federal Government in treatment and rehabilitation pro-
grams for drug addicts and other persons with drug abuse and other
drug dependence problems who are in the area served by the center,
such application may not be approved unless it contains or is sup-
ported by assurances satisfactory to the Secretary that the center will
enter into agreements with departments or agencies of the Government
under which agreements the center may be used (to the maximum
extent practicable) in treatment and rehabilitation programs (if any)
provided by such departments or agencies.
For the purpose of making grants under this part to assist community
mental health centers to meet the requirements of this subsection there are
authorized to be appropriated $60,000,000 for fiscal year ending June 30,
1973, $60,000,000 for the fiscal year ending June 30, 1974, and $60,000,-
000 for the fiscal year ending June 30, 1975."
(b) Section 251 of the Community Mental Health Centers Act (42 U.S. C.
2688k) is amended-
(1) by inserting in subsection (a) "or leasing" after "construction",
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
13
(2) by inserting in subsection (a) `facilities for emergency medical
services, intermediate care services, or outpatient services, or" imme-
diately before "posthospitalization treatment facilities",
(3) by inserting in subsection (a) "or leased" after "constructed",
and
(4) by inserting in subsection (b) "or leasing" after "construction"
the first time it appears.
(c) Section 256(e) of the Community Mental Health Centers Act (42
U.S. C. 2688n-1) is amended (1) by striking out "and $35,000,000" and
inserting in lieu thereof "$60,000,000", and (2) by striking out the period
at the end and inserting in lieu thereof "; and $75,000,000 for the fiscal
year ending June 30, 1974.".
? 402. Public Health Service facilities.
(a) Section 341 (a) of the Public Health Service Act (42 U.S.C. 257(a))
(relating to care and treatment of narcotic addicts and other drug abusers)
is amended by adding at the end thereof the following new sentence: "In
carrying out this subsection, the Secretary shall establish in each hospital
and other appropriate medical facility of the Service a treatment and
rehabilitation program for drug addicts and other persons with drug abuse
and drug dependence problems who are in the area served by such hospital
or other facility; except that the requirement of this sentence shall not
apply in the case of any such hospital or other facility with respect to
which the Secretary determines that there is not sufficient need for such a
program in such hospital or other facility."
(b) Section 341 of that Act is amended by adding at the end thereof the
following new subsection:
"(c) The Secretary may enter into agreements with the Administrator
of Veterans' Affairs, the Secretary of Defense, and the head of any other
department or agency of the Government under which agreements hospitals
and other appropriate medical facilities of the Service may be used in
treatment and rehabilitation programs provided by such department or
agency for drug addicts and other persons with drug abuse and other
drug dependence problems who are in areas served by such hospitals or
other facilities."
? 403. State plan requirements.
(a) Section 314 (d) (2) (K) of the Public Health Service Act (42 U.S. C.
246(d) (2) (K)) is amended by inserting after "problem" the following:
", and include provisions for (i) licensing or accreditation of facilities in
which treatment and rehabilitation programs are conducted for persons
with drug abuse and other drug dependence problems, and (ii) expansion
of State mental health programs in the field of drug abuse and drug
dependence and of other prevention and treatment programs in such field".
(b) Section 204 of the Community Mental Health Centers Act (42
U.S. C. 2684) is amended by adding at the end thereof the following new
subsection:
"(c) After June 30, 1973, the Secretary may not approve any State
plan unless it provides for treatment and prevention programs in the field
of drug abuse and drug dependence, commensurate with the extent the problem, and it includes the provisions required by section 314(y)
(2) (K) of the Public Health Service Act for State plans submitted under
section 314(d) of such Act."
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
S. Rept. 700 0, 92-2--3
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
14
404. Drug abuse prevention function appropriations.
Any request for appropriations by a department or agency of the
Government submitted after the date of enactment of this Act shall specify
(1) on a line item basis, that part of the appropriations which the depart-
ment or agency is requesting to carry out its drug abuse prevention
functions, and (2) the authorization of the appropriations requested to
carry out each of its drug abuse prevention functions.
? 405. Special reports by the Secretary of Health, Education, and
Welfare.
(a) The Secretary of Health, Education, and Welfare (hereinafter in
this title referred to as the "Secretary") shall develop and submit to the
Congress and the Director within ninety days after the date of enact-
ment of this Act, a written plan for the administration and coordina-
tion of all drug abuse prevention functions within the Department of
Health, Education, and Welfare. Such report shall list each program
conducted and each service provided in carrying out such functions,
describe how such programs and services are to be coordinated, and describe
the steps taken or to be taken to insure that such programs and services
will be administered so as to encourage the broadest possible participation
of professionals and paraprofessionals in the fields of medicine, science,
the social sciences, and other related disciplines. The plan shall be con-
sistent with the policies, priorities, and objectives established by the
Director under section 221 of this Act.
(b) The Secretary shall submit to the Director, for inclusion in the
annual report required by section 233 of this Act, a report describing
model and experimental methods and programs for the treatment and
rehabilitation of drug abusers, and describing the advantages of each
such method and program and an evaluation of the success or failure of
each such method or program. The Secretary's report shall contain
recommendations for the development of new and improved methods
and programs for the treatment and rehabilitation of drug abusers,
for community implementation of such methods and programs, and
for such legislation and administrative action as he deems appropriate,
? 406. Additional drug abuse prevention functions of the Secretary
of Health, Education, and Welfare.
(a) The Secretary shall
(1) operate an information center for the collection, preparation,
and dissemination of all information relating to drug abuse pre-
vention functions, including information concerning State and local
drug abuse treatment plans, and the availability of treatment resources,
training and educational programs, statistics, research, and other
pertinent data and information;
(2) investigate and publish information concerning uniform
methodology and technology for determining the extent and kind of
drug use by individuals and effects which individuals are likely to
experience from such use;
(3) gather and publish statistics pertaining to drug abuse and
promulgate regulations specifying uniform statistics to be furnished,
records to be maintained', and reports to be submitted, on a volun-
tary basis by public and private entities and individuals respecting
drug abuse; and
(4) review, and publish an evaluation of, the adequacy and
appropriateness o any provision relatin to dru abuse revention
Approved For Release 2000/09 CI
/08: A-RDP73BOO296R00~40008~ 001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
15
functions contained in the comprehensive State health, welfare,
or rehabilitation plans submitted to the Federal Government pursuant
to Federal law, including, but not limited to, those submitted pursuant
to section 5(a) of the Vocational Rehabilitation Act, sections 314(d)
(2) (K) and 604(a) of the Public health Service Act, section 1902(a)
of title XIX of the Social Security Act, and section 204 (a) of part A
of the Community Mental Health Centers Act.
(b) After December 31, 1974, the Secretary shall carry out hisjunctions
under subsection (a) through the National Institute on Drug Abuse.
? 407. Admission of drug abusers to hospitals for emergency treat-
ment.
(a) Drug abusers who are suffering from emergency medical conditions
shall not be refused admission or treatment, solely because of their drug
abuse or drug dependence, by any private or public general hospital which
receives support in any form from any program supported in whole or in
part by funds appropriated to any Federal department or agency.
(b) The Secretary is authorized to make regulations for the enforcement
of the policy of subsection (a). Such regulations shall include procedures
for determining (after opportunity for a hearing if requested) if a viola-
tion of subsection (a) has occurred, notification of failure to comply
with such subsection, and opportunity for a violator to comply with such
subsection. If the Secretary determines'
etermines that a hospital has violated sub-
section (a) and such violation continues after an opportunity has been
afforded for compliance, the Secretary is authorized to suspend or revoke,
after opportunity for a hearing, all or part of any support of any kind
received by such hospital from any program administered by the Secretary.
The Secretary may consult with the officials responsible for the adminis-
tration of any other Federal program from which such hospital receives
support of any kind, with respect to the suspension or revocation of
Federal support for such hospital.
? 408. Confidentiality of patient records.
(a) Records of the identity, diagnosis, prognosis, or treatment of any
patient which are maintained in connection with the performance of any
drug abuse prevention function authorized or assisted under any provision
of this Act or any Act amended by this Act shall be confidential and may
be disclosed only for the purposes and under the circumstances expressly
authorized under subsection (b) of this section.
(b) (1) If the patient, with respect to whom any given record referred to
in subsection (a) of this section is maintained, gives his written consent,
the content of such record may be disclosed
(A) to medical personnel for the purpose of diagnosis or treatment
of the patient, and
(B) to governmental personnel for the purpose of obtaining benefits
to which the patient is entitled.
(2) If the patient, with respect to whom any given record referred to in
subsection (a) of this section is maintained, does not give his written con-
sent, the content of such record may be disclosed as follows:
(A) To medical personnel to the extent necessary to meet a bona fide
medical emergency.
(B) To qualified personnel for the purpose of conducting scien-
tific research, management or financial audits, or program evalua-
tion, but such personnel may not identify, directly or indirectly, any
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
individual patient in any report of such research, audit, or evalua-
tion, or otherwise disclose patient identities in any manner.
(C) If authorized by an appropriate order of a court of competent
jurisdiction granted after application showing good cause therefor.
In assessing good cause the court shall weigh the public interest
and the need for disclosure against the injury to the patient, to the
physician patient relationship, and to the treatment services. Upon
the granting of such order, the court, in determining the extent to
which any disclosure of all or any part of any record is necessary,
shall impose appropriate safeguards against unauthorized disclosure.
(c) Except as authorized by a court order granted under subsection
(b) (2) (C) of this section, no record referred to in subsection (a) may be
used to initiate or substantiate any criminal charges against a patient or
to conduct any investigation of a patient.
(d) The prohibitions of this section continue to apply to records
concerning any individual who has been a patient, irrespective of whether
or when he ceases to be a patient.
(e) Except as authorized under subsection (b) of this section, any
person who discloses the contents of any record referred to in subsection
(a) shall be fined not more than $500 in the case of a first offense, and not
more than $5,000 in the case of each subsequent offense.
? 409. Formula grants.
(a) There are authorized to be appropriated $15,000,000 for the fiscal
year ending June 30, 1972, $30,000,000 for the fiscal year ending June 80,
1973,$40,000,000 for the fiscal year ending June 30, 1974, and $45,000,-
000 for the fiscal year ending June 30, 1975, for grants to States in
accordance with this section. For the purpose of this section, the term
"State" includes the District of Columbia, the Virgin Islands, the Common-
wealth of Puerto Rico, Guam, American Samoa, and the Trust Territory
of the Pacific Islands, in addition to the fifty States.
(b) Grants to States may be made under this section
(1) for the preparation of plans which are intended to meet the
requirements of subsection (e) of this section;
(2) for the expenses (other than State administrative expenses) of
(A) carrying out projects under and otherwise implementing plans
approved by the Secretary pursuant to subsection (f) of this section,
and (B) evaluating the results of such plans as actually implemented;
and
(8) for the State administrative expenses of carrying out plans
approved by the Secretary pursuant to subsection (f) of this section,
except that no grant under this paragraph to any State for any year
may exceed $50,000 or 10 per centum of the total allotment of that
State for that year, whichever is less.
(c) (1) For each fiscal year the Secretary shall, in accordance with regula-
tions, allot the sums appropriated pursuant to subsection (a) for such
year among the States on the basis of the relative population, financial need,
and the need for more effective conduct of drug abuse prevention functions,
except that no such allotment to any State (other than the Virgin Islands,
Guam, American Samoa, and the Trust Territory of the Pacific Islands),
shall be less than $100,000 multiplied by a fraction whose numerator is the
amount actually appropriated for the purposes of this section for the fiscal
year for which the allotment is made, and whose denominator is the amount
authorized to be appropriated by subsection (a) for that year.
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
17
(2) Any amount allotted under paragraph (1) of this subsection to a
State (other than the Virgin Islands, American Samoa, Guam, and the
Trust Territory of the Pacific Islands) and remaining unobligated at
the end of such year shall remain available to such State, for the purposes
for which made, for the next fiscal year (and for such year only), and
any such amount shall be in addition to the amounts allotted to such
State for such purpose for such next fiscal year; except that any such
amount, remaining unobligated at the end of the sixth month following the
end of such year for which it was allotted, which the Secretary determines
will remain unobligated by the close o such next fiscal year, may be real-
lotted by the Secretary to be available for the purposes for which made until
the close of such, next fiscal year, to other States which have need therefor,
on such basis as the Secretary deems equitable and consistent with the pur-
poses of this section, and any amount so reallotted to a State shall be in
addition to the amounts allotted and available to the States for the same
period. Any amount allotted under paragraph (1) of this subsection to the
Virgin Islands, American Samoa, Guam, or the Trust Territory of the
Pacific Islands for a fiscal year and remaining unobligated at the end of
such year shall remain available to it, for the purposes for which made,
for the next two fiscal years (and for such years only), and any such
amount shall be in addition to the amounts allotted to it for such purpose
for each of such next two fiscal years; except that any such amount,
remaining unobligated at the end of the first of such next two years, which
the Secretary determines will remain unobligated at the close of the second
of such next two years, may be reallotted by the Secretary, to be available
for the purposes for which made until the close of the second of such next
two years, to any other of such four States which have need therefor, on such
basis as the Secretary deems equitable and consistent with the purposes of
this section, and any amount so reallotted to a State shall be in addition to
the amounts allotted and available to the State for the same period.
(d) No grant may be made under subsection (b) (1) of this section
unless an application therefor has been submitted to, and approved by,
the Secretary. Such application shall be in such form, submitted in such
manner, and contain such information, including assurances satisfactory
to the Secretary that the grant will be used by the State for the preparation
of a State plan which will meet the requirements of subsection (e), as the
Secretary shall by regulation prescribe.
(e) Any State desiring to receive a grant under subsection (b) (2) or
(b) (3) of this section shall submit to the Secretary a State plan for planning,
establishing, conducting, and coordinating projects for the development
of more effective drug abuse prevention functions in the State and for
evaluating the conduct of such functions in the State. Each State plan
shall
(1) designate or establish a single State agency as the sole agency
for the preparation and administration of the plan, or for supervising
the preparation and administration of the plan;
(2) Contain satisfactory evidence that the State agency designated
or established in accordance with paragraph (1) will have authority
to prepare and administer, or supervise the preparation and admin-
istration of, such plan in conformity with this subsection;
(3) provide for the designation of a State advisory council which
shall include representatives of nongovernmental organizations or
groups, and of public agencies concerned with the prevention and
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
1s
treatment of drug abuse and drug dependence, from diijerent geo-
graphical areas of the State, and which shall consult with the State
agency in carrying out the plan;
(4) describe the drug abuse prevention functions to be carried out
under the plan with assistance under this section;
(5) set forth, in accordance with criteria established by the Secretary,
a detailed survey of the local and State needs for the prevention and
treatment of drug abuse and drug dependence, including a survey.
of the health facilities needed to provide services for drug abuse and
drug dependence, and a plan for the development and distribution of
such facilities and programs throughout the State;
(6) provide for coordination of existing and planned treatment and
rehabilitation programs and activities, particularly in urban centers;
(7) provide a scheme and methods of administration which will
supplement, broaden, and complement State health plans developed
under section 8.14(d)(2) of the Public Health Service Act;
(8) provide such methods of administration of the State plan,
including methods relating to the establishment and maintenance of
personnel standards on a merit basis (except that the Secretary shall
exercise no authority with respect to the selection, tenure of office, or
compensation of any individual employed in accordance with such
methods), as are found by the Secretary to be necessary for the proper
and efficient operation of the plan;
(9) provide that the State agency will make such reports, in such
form and containing such information as the Secretary may from
time to time reasonably require, and will keep such records and af-
ford such access thereto as the Secretary may find necessary to as-
sure the correctness and verification of such reports;
(10) provide that the State agency will from time to time, but not
less often than annually, review its State plan and submit to the
Secretary an analysis and evaluation of the effectiveness of the pre-
vention and treatment programs and activities carried out under the
plan, and any modifications in the plan which it considers necessary;
(11) provide reasonable assurance that Federal funds made avail-
able under this section for any period will be so used as to supplement
and increase, to the extent feasible and practical, the level of State,
local, and other non-Federal funds that would in the absence of such
Federal funds be made available for the programs described in this
section, and will in no event supplant such State, local, and other
non-Federal funds; and
(12) contain such additional information and assurance as the
Secretary may find necessary to carry out the provisions of this section.
(f) The Secretary shall approve any State plan and any modification
thereof which complies with the provisions of subsection (e) of this section.
(g) From the allotment of a State, the Secretary shall make grants to
that State in accordance with this section. Payments under such grants
may be made in advance or by way of reimbursement and in such install-
ments as the Secretary may determine.
? 410. Special project grants and contracts.
(a) The Secretary shall
(1) make grants to public and private nonprofit agencies, organiza-
tions, or institutions and enter into contracts with public and private
agencies, organizations, institutions, and individuals to provide
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-R1DP73B00296R000400080001-9
training seminars, educational programs, and technical assistance
for the development of drug abuse prevention, treatment, and rehabili-
tation programs for employees in the private and public sectors;
(2) make grants to public and private nonprofit agencies, organiza-
tions, or institutions and enter into contracts with public and private
agencies, organizations, and institutions, to provide directly or
through contractual arrangements for vocational rehabilitation
counseling, education, and services for the benefit of persons in
treatment programs and to encourage efforts by the private and public
sectors of the economy to recruit, train, and employ participants in
treatment programs;
(3) make grants to public and private nonprofit agencies, organi-
zations, or institutions and enter into contracts with public and
private agencies, organizations, institutions and individuals to
establish, conduct, and evaluate drug abuse prevention, treatment,
and rehabilitation programs within State and local criminal justice
systems;
(4) make grants to or contracts with groups composed of individuals
representing a broad cross -section of medical, scientific, or social
disciplines for the purpose of determining the causes of drug abuse
in a particular area, prescribing methods for dealing with drug abuse
in such an area, or conducting programs for dealing with drug abuse
in such an area;
(5) make research grants to public and private nonprofit agencies,
organizations, and institutions and enter into contracts with public
and private agencies, organizations, and institutions, and individuals
for improved drug maintenance techniques or programs; and
(6) make grants to public and private nonprofit agencies, organiza-
tions, and institutions and enter into contracts with public and pri-
vate agencies, organizations, institutions, and individuals to establish,
conduct, and evaluate drug abuse prevention and treatment programs.
(b) There are authorized to be appropriated $25,000,000 for the fiscal
year ending June 80, 1972; $65,000,000 for the fiscal year ending
June 80, 1973; $100,000,000 for the fiscal year ending June 30, 1974;
and $160,000,000 for the fiscal year ending June 30, 1975, to carry out
this section.
(c) (1) In carrying out this section, the Secretary shall require coordina-
tion of all applications for programs in a State and shall not give prece-
dence to public agencies over private agencies, institutions, and organiza-
tions, or to State agencies over local agencies.
(2) Each applicant within a State, upon filing its application with the
Secretary for a grant or contract under this section, shall submit a copy
of its application for review by the State agency (if any) designated or
established under section 409. Such State agency shall be given not more
than thirty days from the date of receipt of the application to submit to
the Secretary, in writing, an evaluation of the project set forth in the appli-
cation. Such evaluation shall include comments on the relationship of the
project to other projects pending and approved and to the State compre-
hensive plan for treatment and prevention of drug abuse under section 409.
The State shall furnish the applicant a copy of any such evaluation. A
State if it so desires may, in writing, waive its rights under this paragraph.
(3) Approval of any application for a grant or contract under this
section by the Secretary, including the earmarking of financial assistance
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
20
for a program or project, may be granted only if the application sub-
stantially meets a set of criteria that
(A) provide that the activities and services for which assistance
under this section is sought will be substantially administered by or
under the supervision of the applicant,-
(B) provide for such methods of administration as are necessary
for the proper and efficient operation of such programs or projects;
(C) provide for such fiscal control and fund accounting procedures
as may be necessary to assure proper disbursement of and accounting
for Federal funds paid to the applicant; and
(D) provide for reasonable assurance that Federal funds made
available under this section for any period will be so used as to
supplement and increase, to the extent feasible and practical, the
level of State, local, and other non-Federal funds that would in the
absence of such Federal funds be made available for the programs
described in this section, and will in no event supplant such State,
local, and other non-Federal funds.
(d) Payment under grants or contracts under this section may be made
in advance or by way of reimbursement and in such installments as the
Secretary may determine.
? 411. Records and audit.
(a) Each recipient of assistance under section 409 or 410 pursuant to
grants or contracts entered into under other than competitive bidding
procedures shall keep such records as the Secretary shall prescribe,
including records which fully disclose the amount and disposition by
such recipient of the proceeds of such grant or contract, the total cost of
the project or undertaking in connection with which such grant or contract
is given or used, and the amount of that portion of the cost of the project
or undertaking supplied by other sources, and such other records as will
facilitate an effective audit.
(b) The Secretary and Comptroller General of the United States, or
any of their duly authorized representatives, shall have access for the
purpose of audit and examination to any books, documents, papers, and
records of such recipients that are pertinent to such grants or contracts.
? 412. National Drug Abuse Training Center.
(a) The Director shall establish a National Drug Abuse Training
Center (hereinafter in this section referred to as the "Center") to develop,
conduct, and support a full range of training programs relating to drug
abuse prevention functions. The Director shall consult with the National
Advisory Council for Drug Abuse Prevention regarding the general policies
of the Center. The Director may supervise the operation of the Center ini-
tially, but shall transfer the supervision of the operation of the Center to the
National Institute on Drug Abuse not later than December 31, 1974.
(b) The Center shall conduct or arrange for training programs, semi-
nars, meetings, conferences, and other related activities, including the
furnishing of training and educational materials for use by others.
(c) The services and facilities of the Center shall, in accordance with
regulations prescribed by the Director, be available to (1) Federal, State,
and local government oficials, and their respective staffs, (2) medical and
paramedical personnel, and educators, and (3) other persons, including
drug dependent persons, requiring training or education in drug abuse
prevention.
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
21
(d) (1) For the purpose of carrying out this section, there are authorized
to be appropriated $1,000,000 for the fiscal year ending June 30, 1972,
$3,000,000 for the fiscal year ending June 30, 1973, $5,000,000 for the
fiscal year ending June 30, 1974, and $6,000,000 for the fiscal year
ending June 30, 1975.
(2) Sums appropriated under this subsection shall remain available
for obligation or expenditure in the fiscal year for which appropriated
and in the fiscal year next following.
? 413. Drug abuse among Federal civilian employees.
(a) The Civil Service Commission shall be responsible for developing
and maintaining, in cooperation with the Director and with other Federal
agencies and departments, appropriate prevention, treatment, and re-
habilitation programs and services for drug abuse among Federal civilian
employees. Such policies anti services shall make optimal use of existing
governmental facilities, services, and skills.
(b) The Director shall foster similar drug abuse prevention, treatment,
and rehabilitation programs and services in State and local governments
and in private industry.
(c) (1) No person may be denied or deprived of Federal civilian employ-
ment or a Federal professional or other license or right solely on the
ground of prior drug abuse.
(2) This subsection shall not apply to employment (A) in the Central
Intelligence Agency, the Federal Bureau of Investigation, the National
Security Agency, or any other department or agency of the Federal Govern-
ment designated for purposes of national security by the President, or (B)
in any position in any department or agency of the Federal Government,
not referred to in clause (A), which position is determined pursuant to
regulations prescribed by the head of such department or agency to be a
sensitive position.
(d) This section shall not be construed to prohibit the dismissal from
employment of a Federal civilian employee who cannot properly function
in his employment.
TITLE V-NATIONAL INSTITUTE ON DRUG ABUSE;
NATIONAL ADVISORY COUNCIL ON DRUG ABUSE
Sec.
501. Establishment of Institute.
502. Establishment of National Advisory Council on Drug Abuse.
? 501. Establishment of Institute.
(a) Effective December 31, 1974, there is established, in the National
Institute of Mental Health, a National Institute on Drug Abuse (herein-
after in this section referred to as the "Institute") to administer the pro-
grams and authorities of the Secretary of Health, Education, and Welfare
(hereinafter in this section referred to as the "Secretary") with respect to
drug abuse prevention functions. The Secretary, acting through the
Institute, shall, in carrying out the purposes of section 301 of the Public
Health Service Act with respect to drug abuse, develop and conduct com-
prehensive health, education, training, research, and planning programs
for the prevention and treatment of drug abuse and for the rehabilitation of
drug abusers.
O The Institute shall be under the direction of a Director who shall be
appointed by the Secretary.
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
22
(c) The programs of the Institute shall be administered so as to encourage
the broadest possible participation of professionals and paraprofessionals
in the fields of medicine, science, the social sciences, and other related
disciplines.
? 502. Establishment of National Advisory Council on Drug Abuse.
(a) Section 217 of the Public Health Service Act is amended by adding
at the end thereof the following new subsection:
"(e) (1) The National Advisory Council on Drug Abuse shall consist
of the Secretary, who shall 'be Chairman, the chief medical officer of the
Veterans' Administration or his representative, and a medical officer
designated by the Secretary of Defense, who shall be ex officio members.
In addition, the Council shall be composed of twelve members appointed
by the Secretary without regard to the provisions of title 5, United States
Code, governing appointments in the competitive service. The appointed
members of the Council shall represent a broad range of interests, disci-
plines, and expertise in the drug area and shall be selected from outstand-
ing professionals and paraprofessionals in the fields of medicine, educa-
tion, science, the social sciences, and other related disciplines, who have
been active in the areas of drug abuse prevention, treatment, rehabilitation,
training, or research.
"(2) The Council shall advise, consult with, and make recommendations
to, the Secretary
"(A) concerning matters relating to the activities and functions of
the Secretary in the field of drug abuse, including, but not limited to,
the development of new programs and priorities, the efficient admin-
istration of programs, and the supplying of needed scientific and
statistical data and program information to professionals, para-
professionals, and the general public; and
"(B) concerning policies and priorities respecting grants and
contracts in the field of drug abuse."
(b) Section 266 of the Community Mental Health Centers Act is
amended
(1) by striking out in the first sentence "part C" and inserting
in lieu thereof "parts C and D",
(2) by striking out in the second sentence "established by such
section", and
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
23
(8) by adding at the end the following new sentence: "Grants
under part D of this title for such costs will undergo such review as
is provided by section 217(e) of the Public Health Service Act."
And the House agree to the same.
HARLEY 0. STAGGERS,
PAUL G. ROGERS,
DAVID E. SATTERFIELD,
PETER N. KYROS,
RICHARDSON PREYER,
JAMES W. SYMINGTON,
WILLIAM R. Roy,
WILLIAM L. SPRINGER,
ANCHER NELSEN,
TIM LEE CARTER,
JAMES F. HASTINGS,
Managers on the Part of the House.
JOHN L. MCCLELLAN,
ABE RIBICOFF,
LEE METCALF,
LAWTON CHILES,
CHARLES PERCY,
JACOB K. JAVITS,
EDWARD J. GURNEY,
HAROLD E. HUGHES,
JENNINGS RANDOLPH,
HARRISON A. WILLIAMS, Jr.,
EDWARD M. KENNEDY,
WALTER F. MONDALE,
ALAN CRANSTON,
BOB PACKWOOD,
PETER H. DOMINICK,
RICHARD S. SCHWEIKER,
Managers on, the Part of the Senate.
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
JOINT EXPLANATORY STATEMENT OF THE
COMMITTEE OF CONFERENCE
The managers on the part of the House and the Senate at the con-
ference on the disagreeing votes of the two Houses on the amendment
of the House to the bill (S. 2097) to establish a Special Action Office
for Drug Abuse Prevention and to concentrate the resources of the
Nation against the problem of drug abuse, submit the following joint
statement to the House and the Senate in explanation of the effect
of the action agreed upon by the managers and recommended in the
accompanying conference report:
The amendment of the House to the bill is a substitute for the en-
tire text of the Senate bill. The conference substitute is a substitute
for the text of both the Senate bill and the House amendment. Except
for technical, clerical, clarifying, and conforming changes, the dif-
ferences between the conference substitute and the Senate bill and
House amendment are set out below:
The Senate bill contained a specific listing of programs to which
the legislation was applicable; the House amendment included these
programs through specifically defining the terms "drug abuse pre-
vention function" and "drug traffic prevention function".
The Senate bill included, but was not limited to, the following:
(1) the Narcotic Addict Rehabilitation Act of 1966
including treatment and aftercare programs of the Na-
tional Institute of Mental Health and the Bureau of
Prisons of the Department of Justice;
(2) part D and part E (to the extent such parts
pertain to drug abuse) of the Community Mental
Health Centers Act including treatment, rehabilita-
tion, and education projects administered by the
National Institute of Mental Health;
(3) title I of the Comprehensive Drug Abuse Pre-
vention and Control Act of 1970 including treatment,
rehabilitation, and education projects authorized by
the Secretary of Health, Education, and Welfare;
(4) section 502(a)(1) of the Comprehensive Drug
Abuse Prevention and Control Act of 1970, to the
extent it pertains to public education programs not
involving law enforcement within the Bureau of Nar-
cotics and Dangerous Drugs of the Department of
Justice;
(5) the Drug Abuse Education Act of 1970 admin-
istered by the Office of Education of the Department of
Health, Education, and Welfare;
(24)
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIADP73B00296R000400080001-9
(6) section 222 (a) (9) of the Economic Opportunity
Act of 1964 and all other provisions of that Act, to the
extent they pertain to drug abuse, including community
treatment and rehabilitation projects administered by
the Office of Economic Opportunity;
(7) section 306(a) (2) of the Omnibus Crime Control
and Safe Streets Act of 1968, to the extent that it
pertains to drug abuse, including treatment, rehabilita-
tion, and education projects administered by the Law
Enforcement Assistance Administration of the Depart-
ment of Justice;
(8) the Manpower Development and Training Act
of 1962, to the extent it pertains to drug abuse, includ-
ing rehabilitation projects administered by the Depart-
ment of Labor;
(9) the Public Health Service Act, to the extent it
pertains to drug abuse, including service, research, and
training programs administered by the Department
of Health, Education, and Welfare;
(10) title 38 of the United States Code, to the ex-
tent such title pertains to drug abuse, including treat-
ment and rehabilitation services conducted by the Vet-
erans' Administration; and
(11) grant programs authorized by the conference
substitute.
The conference substitute is the same as the House amendment,
and covers the designated programs, as well as any other programs or
activities falling within the defined term "drug abuse prevention
function", whether or not conducted by an agency to whose primary
mission drug abuse prevention functions are incidental.
ACCESS TO PERSONNEL AND INFORMATION
Both the Senate bill and the House amendment provided for estab-
lishment of the Special Action Office for Drug Abuse Prevention in
the Executive Office of the President. The House amendment provided
that the establishment of the Office in the Executive Office shall not
affect congressional access to (1) information, documents, and studies
in the possession of, or conducted by, the Office or (2) personnel of the
Office.
The conference substitute is the same as the House bill.
APPOINTMENTS
The Senate bill authorized the appointment of 25 persons without
regard to civil service and compensation laws, with up to 10 persons
permitted to be paid at rates up to GS-18, and 15 additional could
be paid at rates up to GS-13.
The House amendment contained no comparable provision.
The conference substitute provides that, in addition to the number
of positions which may be placed in supergrades under normal Civil
Service Commission procedures, not to exceed 10 positions in the
Office may be placed in grades GS-16, 17, and 18, in accordance with
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
26
the procedures prescribed under section 5108 of title 5, United States
Code.
This revised authority will permit the Office to employ the person-
nel they need for top positions, while preserving the jurisdiction of
the Civil Service Commission and the congressional committees having
an interest in this subject.
Both the Senate bill and the House amendment authorized appoint-
ments of experts and consultants, but the House amendment, and the
conference substitute, permit such employment without regard to
limitations on the length of service.
ADVISORY COUNCIL
The House amendment provided for the establishment of a National
Advisory Council for Drug Abuse Prevention consisting of the Secre-
tary of EW, the Secretary of Defense, the Administrator of Veterans'
Affairs, ex officio, or their designees, and 12 members appointed by the
President, of whom four must be State or local officials concerned with
drug abuse prevention functions. The Director is required, in carrying
out his overall planning and policy functions, to consult from time to
time with the National Advisory Council.
The Senate bill contained no corresponding provision.
The conference substitute is the same as the House bill.
LIAISON
The House amendment provided for the appointment of an Assistant
Director to maintain communication and liaison with Federal agencies
performing drug traffic prevention functions.
The Senate bill contained no corresponding provision.
-The conference substitute is the same as the House amendment.
CONCENTRATION OF FEDERAL EFFORT
The Senate bill provided that the Director shall coordinate drug
abuse programs and activities carried out by the United States, and
shall coordinate such programs and activities with other programs
and activities of the United States, if it will aid the Federal effort
'--The House amendment contained no corres
ondin
r
i
io
p
g p
ov
s
n.
The conference substitute is the same as the Senate bill, with the
addition of a specific reference to the second sentence of section 213
of the legislation, which provides that the authority of the Director
shall not be construed to limit the authority of the Secretary of
Defense with respect to the operation of the Armed Forces, or the
authority of the Administrator of Veterans' Affairs with respect to
furnishing health care to veterans, except with respect to overall
policies established by the Director relating to the conduct of drug
abuse prevention functions.
The legislation contemplates that the Director and his staff will act
as, a catalyst to improve the organization and operation of Federal
drug abuse programs. The Director is to play an active role in estab-
lishing budget levels, program priorities and policies aimed at curbing
drug abuse. The conferees also intend that he monitor agency per-
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
27
formance to find and correct failures, weaknesses and delays in policy
implementation. In addition, the conferees expect that the Director
will take the lead in adjusting and reconciling any policy differences
between Federal agencies concerning drug abuse.
The conferees reaffirm the intention of this legislation that the
Special Action Office concentrate its efforts on interagency coordina-
tion and policy development. It must not attempt to manage or
intervene in the routine operation of programs conducted by the
departments and agencies. Such action would be contrary to the ex-
press purpose of the bill and would waste the resources of the office.
The conferees do intend, however, that the Director be fully informed
concerning the operation of agency programs affecting drug abuse
prevention or traffic functions, to assure that the overall policies he
has set are being complied with and implemented. If the Special
Action Office is to play a constructive role, it must focus its activities
on those areas directly related to its mission-assuring cooperation
between departments and agencies on policy issues which cut across
jurisdictional lines, providing and encouraging rigorous evaluation of
existing programs, and fostering new and innovative approaches to
the drug abuse problem.
DEVELOPMENT OF METHODS TO DETERMINE EXTENT OF DRUG ABUSE IN
UNITED STATES
The House amendment included as one of the duties of the Director
the development of improved methods for determining the extent of
drug addiction and abuse in the United States.
The Senate bill contained no comparable provision.
The conference substitute is the same as the House amendment.
The Senate bill provided that the Director, in carrying out his
overall planning and policy functions, is to perform such other func-
tions as the President may assign.
The House amendment contained no such provision, and the con-
ference substitute is the same as the House amendment. Section 232
authorizes the President to designate the Director to represent the
United States in discussions and negotiations relating to drug abuse
prevention, drug traffic prevention, or both.
The House amendment provides that the Director shall encourage
and promote research to create, develop, and test nonaddictive syn-
thetic analgesics to replace opium, long lasting nonaddictive blocking
or antagonistic drugs, and detoxification agents, for heroin.
The Senate bill did not contain such authority for the Director,
but authorized similar authority through grants and contracts entered
into by the Secretary of Health, Education, and Welfare.
The conference substitute is the same as the House bill, with
authorization of $30,000,000 for fiscal year 1975.
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
28
APPROPRIATION AUTHORIZATIONS
The Senate bill authorized appropriations totaling $42,000,000 for
functions of the Director, and $160,000,000 for the special fund, with
authorizations for fiscal years 1972 through 1975.
The House amendment authorized $25,000,000 for fiscal years 1972
through 1974 for functions of the Director, and $80,000,000 for fiscal
years 1973 and 1974 for the special fund.
The conference substitute authorizes, for functions of the Director,
$5,000,000 for fiscal year 1972, $10,000,000 for fiscal year 1973,
$11,000,000 for fiscal year 1974, and $12,000,000 for fiscal 1975.
With respect to the special fund, $40,000,000 is authorized for each
of the fiscal years 1973, 1974, and 1975. Funds appropriated for one
fiscal year but not expended therein may be carried over to the next
fiscal year.
Under the conference agreement, the Director's authority will
extend for three full fiscal years ending June 30, 1975, plus the re-
mainder of the current fiscal year.
NATIONAL DRUG ABUSE TRAINING CENTER
The House amendment authorized $2,000,000 for fiscal year 1972,
$3,000,000 for fiscal year 1973, and $5,000,000 for fiscal year 1974,
for the Director to develop, conduct, and support training programs
relating to prevention of drug abuse, with the operation of the Center
to be transferred to the National Institute of Mental Health prior
to the termination of the Director's powers.
The Senate bill contained no comparable provision.
The conference substitute is, the same as the House amendment
except that the Director's role with respect to the training center is
to be that of overall supervision; the Center is to be transferred to
the National Institute of Drug Abuse (created by other provisions in
the bill) as of December 31, 1974. The appropriation authorizations are
set at $1,000,000 for fiscal year 1972, $3,000,000 for fiscal year 1973,
$5,000,000 for fiscal year 1974, and $6,000,000 for fiscal year 1975.
FEDERAL PERSONNEL POLICIES
The Senate bill provided that the Civil Service Commission would
establish policies for control and treatment of drug abuse among
Federal civilian employees (including employees of the Postal Service),
and that drug dependent employees were not to lose benefits, and
where possible to be provided employment, during rehabilitation.
The House amendment provided that the Director should advise
the Civil Service Commission and other agencies as to policies and
services for control. and treatment of drug abuse among Federal
civilian employees.
The conference substitute is the same, with respect to drug abuse, as
section 201 of the Alcohol and Alcohol Abuse Prevention and Treat-
ment Act of 1970, is with respect to alcoholism and alcohol abuse by
Federal employees.
Employees of the Postal Service were removed from this section at
the request of the Postal Service as inconsistent with the nongovern-
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
mental status of such employees under the Postal Reorganization
Act. The Postal Service stated that it was their intention to make
every effort to cooperate with the Special Action Office, and to estab-
lish a program, modeled on that established for other Federal em-
ployees, for the treatment of drug abuse among postal employees.
This section establishes the principle that drug abuse and drug
dependence shall be handled by Federal departments and agencies
as a medical problem for the employee involved. The provision is
almost identical to section 201 of the Alcohol and Alcohol Abuse
Prevention and Treatment Act of 1970, and should be administered
in a similar manner. Thus, except for certain designated sensitive
agencies and sensitive positions, an employee may not be dismissed
solely because of prior drug abuse. Except for the designated agencies
and positions, Federal employees may have their employment termi-
nated only for failure to perform their jobs. All Federal civilian
employees dismissed, including those in the agencies and positions
listed in subsection (c) (2) of this section, are to be treated alike with
respect to retention of collateral benefits. Accordingly, any dismissed
employee's rights to annual and sick leave, medical treatment,
rehabilitation services, pension, and other collateral rights should be
preserved to the same extent as they would be for employees who
have lost their jobs due to other medical disabilities.
The Senate bill provided that the President may change the func-
tions of the Director by reorganization plans without regard to the
cutoff date for the submission of plans and the limits on the number
that may be submitted.
A similar provision in the House version was deleted by an amend-
ment on the House floor, so that the House amendment contained no
comparable provision.
The conference substitute is the same as the House amendment.
The Senate bill provided that the Director should consult with and
be consulted by appropriate officials regarding classification of drugs
under the Controlled Substances Act, and investigational new drugs
with a potential for abuse. The Director had similar responsibilities
with respect to international questions of classification of drugs,
and with respect to New Drug Applications.
The House amendment contained no corresponding provisions.
The conference substitute provides that whenever the Attorney
General determines that there is evidence that a drug which is not a
controlled substance may be subject to abuse, or that a controlled
substance should be transferred or removed from a schedule under
the Controlled Substances Act, he shall, prior to the initiation of a
formal proceeding for such transfer, removal, or control, notify the
Director. In addition, when information is developed with respect to
an investigational new drug indicating that the drug has a potential
for abuse, that information which is forwarded to the Attorney General
as required by the Controlled Substances Act shall also be forwarded
to the Director.
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
The Senate bill provided that veterans would receive treatment and
rehabilitation services for drug dependency irrespective of the nature of
their discharge, the service connection of their drug dependency, or of
any other limitation in title 38, United States Code. Services to veter-
ans would include inpatient treatment and outpatient services irrespec-
tive of any prior inpatient treatment, psychiatric care, counseling,
vocational training, or other rehabilitative services, and the funding,
setting up, or operation of residential halfway houses.
The House amendment contained no corresponding provision.
The conference substitute contains no provision relating to treat-
ment and rehabilitation for veterans. The conferees have noted that
legislation dealing with this subject has passed the House, and is
presently under active consideration by the Senate Veterans' Affairs
Committee.
The removal of this section of the bill by the conferees is based upon
their assumption that separate legislation will be promptly enacted
dealing with the problem of treatment and rehabilitation for veterans,
and is done because of jurisdictional objections raised by the Veterans'
Affairs Committee of the House. The conferees wish to stress, however,
their unanimous firm conviction that dealing with the problem of drug
abuse among returning veterans is a matter of the utmost urgency
and should be accorded the highest priority by the Congress.
The Senate bill provided for the establishment of a comprehensive,
coordinated, long-term Federal strategy for all drug abuse programs
and activities conducted, sponsored, or supported by the United
States.
The House bill contained no comparable provision.
The conference substitute is the same as the Senate bill, with
technical changes.
The House amendment required that applications for staffing grants
for community mental health centers contain assurances that each
such center will provide needed drug abuse treatment and rehabilita-
tion programs to persons in the area to be served, if the Secretary
finds that the problem in the area warrants establishment of such a
program. Appropriations of $60 million for each of the fiscal years
1973 and 1974 are authorized.
The Senate bill contained no comparable provision, but amended
the Community Mental Health Centers Act to authorize grants for
the leasing of facilities for drug abuse treatment programs, and
authorized assistance for facilities for emergency medical services,
intermediate care services, and out-patient services.
The conference substitute combines the provisions of the House
amendment and the Senate bill, with authorization of $60,000,000 for
fiscal year 1975.
The House amendment provided for establishment of drug abuse
treatment and rehabilitation programs in facilities of the Public
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-~QP73B00296R000400080001-9
Health Service to provide services for persons residing in the local
areas, and for servicemen and veterans in such areas.
The Senate bill contained no comparable provision.
The conference substitute is the same as the House bill.
The House amendment requires that State plans for grants for
comprehensive public health services include provisions for licensing
facilities in which drug abuse treatment and rehabilitation programs
are conducted, and for expansion of State mental health programs in
the method of drug abuse prevention and treatment.
The conference substitute is the same as the House amendment,
with a clarifying change.
The House amendment provided that all requests for appropriations
for drug abuse prevention functions must hereafter be submitted on a
line item basis.
The Senate bill contained no comparable provision.
The conference substitute is the same as the House amendment,
with the addition of the requirement that the appropriation request
must also include each specific authorization on the basis of which
the request is made.
The House amendment increased from $35 million to $60 million
the authorization for special projects of programs for drug abuse
treatment and rehabilitation for fiscal year 1973, together with a new
authorization of $75 million for fiscal year 1974.
The conference substitute is the same as the House bill.
The Senate bill provided for the establishment within the National
Institute of Mental Health of a National Institute on Drug Abuse.
The House amendment contained no comparable provision.
The conference substitute is the same as the Senate bill, except that
the new National Institute on Drug Abuse is to be created on Decem-
ber 31, 1974. The postponement will give the Department of HEW
time to prepare for the establishment of the new Institute. The con-
ferees anticipate that, in the consideration of other legislation in the
field of mental health and drug abuse, scheduled for expiration in the
future, further consideration will be given to the proper role and
function of the new Institute.
REPORTS BY THE SECRETARY OF HEALTH, EDUCATION, AND WELFARE
The Senate bill required that the Secretary of Health, Education,
and Welfare submit to Congress a written plan for the administration
and coordination of his drug abuse programs, and describe existing
model and experimental methods for drug abuse treatment, and make
recommendations for future development of treatment techniques.
The House amendment contained no comparable provision.
The conference substitute is the same as the Senate bill.
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
32
The Senate bill provides that the Secretary is to (1) operate an in-
formation center related to drug abuse information, (2) investigate
and publish information concerning methodology and technology for
determining the extent and kind of drug abuse, (3) publish statistics,
and (4) review and evaluate provisions for drug abuse prevention and
treatment programs submitted in State health plans.
The House amendment contained no comparable provision.
The conference substitute is the same as the Senate bill.
The Senate bill established a formula grant program for assisting
States in planning, establishing, maintaining, coordinating, and evalu-
ating projects to deal with drug abuse, with authorization of appropria-
tion of $15,000,000 for fiscal 1972, $30,000,000 for fiscal 1973, $40,000,-
000 for fiscal 1974, $45,000,000 for fiscal 1975, and $50,000,000 for
fiscal 1976.
The House amendment authorized formula grants to assist States
in planning drug abuse prevention functions and in evaluating the
conduct of such functions, with appropriation authorization of
$5,000,000 for fiscal 1972, $13,000,000 for fiscal 1973, and $13,000,000
for fiscal 1974.
The conference agreement is the same as the Senate bill except that
the appropriation authorizations for fiscal 1976 are deleted, and the
minimum allotment to the States contained in the Senate bill is set
at $100,000, with provision for reduction if appropriations are below
authorizations.
GRANTS AND CONTRACTS FOR SPECIAL PROGRAMS
The Senate bill authorized grants and contracts-
(1) for training programs,
(2) for rehabilitation programs,
(3) for drug abuse treatment programs within State and local
criminal justice systems,
(4) to determine the causes of drug abuse,
(5) for research relating to blocking or antagonistic drugs,
improved detoxification agents, and improved drug maintenance
techniques and programs; and
(6) for drug abuse treatment programs on the local level.
Authorization for appropriations were $65,000,000 for fiscal 1972,
$170,000,000 for fiscal 1973, $260,000,000 for fiscal 1974, $400,000,000
for fiscal 1975, and $450,000,000 for fiscal 1976.
The House amendment contained no corresponding provision.
The conference substitute is the same as the Senate bill, except
that the programs for research related to blocking or antagonistic
drugs, and improved detoxification agents are eliminated as covered
by the authority of the Director under section 224 of the bill, and the
appropriation authorizations are as follows: $25 million for fiscal
1972, $65 million for fiscal 1973; $100 million for fiscal 1974; and
$160 million for fiscal 1975.
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
33
ADMISSION OF DRUG ABUSERS TO HOSPITALS
The Senate bill provided that drug abusers who are suffering from
emergency medical conditions shall not be refused admission to or
treatment by any public or private general hospital which receives Fed-
eral assistance, with a suspension or revocation of Federal assistance
for any hospital violating this provision.
The House amendment contained no corresponding provision.
The conference substitute is the same as the Senate bill.
NATIONAL ADVISORY COUNCIL ON DRUG ABUSE
The Senate bill provided for the establishment of a National
Advisory Council on Drug Abuse similar to the other advisory councils
established under the Public Health Services Act, to advise and consult
with the Secretary concerning his functions in the field of drug abuse
and to review and approve grants made for narcotic addiction and
drug dependent person rehabilitation programs under part (D) of
the Community Mental Health Centers Act.
The House amendment contained no corresponding provision.
The conference substitute is the same as the Senate bill.
CONFIDENTIALITY 010 PATIENT RECORDS
The Senate bill provided for confidentiality of private records
prepared or obtained in connection with drug abuse programs, with
some limitations.
The House amendment contained no corresponding provision.
The conference substitute is the same as the Senate bill, with
technical and clarifying changes.
The conferees wish to stress their conviction that the strictest
adherence to the provisions of this section is absolutely essential to
the success of all drug abuse prevention programs. Every patient and
former patient must be assured that his right to privacy will be pro-
tected. Without that assurance, fear of public disclosure of drug abuse
or of records that will attach for life will discourage thousands from
seeking the treatment they must have if this tragic national problem
is to be overcome.
Every person having control over or access to patients' records must
understand that disclosure is permitted only under the circumstances
and conditions set forth in this section. Records are not to be made
available to investigators for the purpose of law enforcement or for
any other private or public purpose or in any manner not specified
in this section.
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
 Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9
34
DESIGNATION OF CERTAIN POSITIONS IN ACTION
The Senate bill contained an amendment to the Economic Oppor-
tunity Act of 1964 providing for two associate directors of ACTION,
to be compensated at Level IV of the Executive Schedule.
The House amendment contained no corresponding provision.
The conference substitute is the same as the House amendment.
JOHN L. MCCLELLAN,
ABE RIBICOFF,
LEE METCALF,
LAWTON CHILES,
CHARLES PERCY,
JACOB K. JAVITS,
EDWARD J. GURNEY,
HAROLD E. HUGHES,
JENNINGS RANDOLPH,
HARRISON A. WILLIAMS, Jr.,
EDWARD M. KENNEDY,
WALTER F. MONDALE,
ALAN CRANSTON,
BOB PACKWOOD,
PETER H. DOMINICK,
RICHARD S. SCHWEIKER
Managers on the Part of the Senate.
HARLEY O. STAGGERS,
PAUL G. ROGERS,
DAVID E. SATTERFIELD,
PETER N. KYROS,
RICHARDSON PREYER,
JAMES W. SYMINGTON,
WILLIAM R. Roy,
WILLIAM L. SPRINGER,
ANCHER NELSEN,
TIM LEE CARTER,
JAMES F. HASTINGS,
Managers on the Part of the House.
O
Approved For Release 2000/09/08 : CIA-RDP73B00296R000400080001-9